Department of Radiology and Radiological Sciences Presents the Annual
Sandler Lecture in Nuclear Medicine and Molecular Imaging
"Radioiodine Treatment for Thyroid Cancer: Why, When and How"
featuring
Anca M. Avram, MD
Professor of Radiology and Internal Medicine
University of Michigan
Ann Arbor, Michigan
Dec. 7, 2021 | Noon - 1 p.m.
Zoom and MCN CCC-1111
Register Here
---------------------------------------------------------------
This grand rounds lecture is designed for faculty, residents, staff and medical students.
Learning objectives of this presentation include the following:
-
Present a comprehensive approach for the diagnostic evaluation and selection of patient-specific therapeutic radioiodine activities for scenarios commonly encountered in clinical practice;
-
Demonstrate state-of-the-art techniques for diagnostic radioiodine scanning and dosimetry;
-
Identify clinical scenarios requiring maximum tolerated I-131 activity treatment.
Learn more about the Sandler Lecture in Nuclear Medicine and Molecular Imaging here.
+++
Anca M. Avram, MD, is Professor of Radiology in the Division of Nuclear Medicine, and Professor of Internal Medicine in the Division of Endocrinology & Metabolism at the University of Michigan. Dr. Avram is certified by the American Board of Internal Medicine, the American Board of Endocrinology & Metabolism, and the American Board of Nuclear Medicine. Dr. Avram is an internationally recognized expert in the field of radiotheragnostics, she has authored 80 peer-reviewed scientific manuscripts, 50 abstract presentations and 10 book chapters. Her clinical interests include radioactive iodine treatment for hyperthyroidism, thyroid cancer and radioimmunotherapy for lymphoma. Dr. Avram’s research interests focus on the role of diagnostic radioiodine imaging for guiding 131-I treatment for thyroid cancer (radiotheranostics), and clinical dosimetry protocols for metastatic thyroid cancer.
